Sahin Ugur
SEC insider (Form 3/4/5 filer). CIK 0002123975. Chief Executive Officer at BioNTech SE (BNTX). 26 reported Form 4/5 transactions since Sep 2024; latest on Oct 9, 2026. Located in MAINZ.
Companies Sahin Ugur has filed insider reports for
- BioNTech SE (BNTX): Officer, 10% Owner, Chief Executive Officer
Sahin Ugur
CIK: 0002123975
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)26 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BNTX
BioNTech SE
Officer10% Owner
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- Oct 9, 2026BNTX
BioNTech SE
SaleDirect36.2K shares at avg. $95.37$3.5M - Oct 8, 2026BNTX
BioNTech SE
SaleDirect27K shares at avg. $92.31$2.5M - Oct 7, 2026BNTX
BioNTech SE
SaleDirect24K shares at avg. $95.86$2.3M - Oct 6, 2026BNTX
BioNTech SE
SaleDirect21K shares at avg. $96.81$2.0M - Oct 5, 2026BNTX
BioNTech SE
SaleDirect72K shares at avg. $97.23$7.0M - Oct 2, 2026BNTX
BioNTech SE
SaleDirect17K shares at avg. $96.72$1.6M - Oct 1, 2026BNTX
BioNTech SE
SaleDirect17K shares at avg. $97.46$1.7M - Sep 30, 2026BNTX
BioNTech SE
SaleDirect32K shares at avg. $98.12$3.1M - Sep 29, 2026BNTX
BioNTech SE
SaleDirect34K shares at avg. $98.26$3.3M - Sep 28, 2026BNTX
BioNTech SE
SaleDirect34K shares at avg. $98.47$3.3M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 9, 2026 | BNTX BioNTech SE | Sale | 36,209 | $95.37 | $3,453,372 | Direct |
| Oct 8, 2026 | BNTX BioNTech SE | Sale | 27,000 | $92.31 | $2,492,483 | Direct |
| Oct 7, 2026 | BNTX BioNTech SE | Sale | 24,000 | $95.86 | $2,300,633 | Direct |
| Oct 6, 2026 | BNTX BioNTech SE | Sale | 21,000 | $96.81 | $2,032,995 | Direct |
| Oct 5, 2026 | BNTX BioNTech SE | Sale | 72,000 | $97.23 | $7,000,646 | Direct |
| Oct 2, 2026 | BNTX BioNTech SE | Sale | 17,000 | $96.72 | $1,644,323 | Direct |
| Oct 1, 2026 | BNTX BioNTech SE | Sale | 17,000 | $97.46 | $1,656,745 | Direct |
| Sep 30, 2026 | BNTX BioNTech SE | Sale | 32,000 | $98.12 | $3,139,850 | Direct |
| Sep 29, 2026 | BNTX BioNTech SE | Sale | 34,000 | $98.26 | $3,340,809 | Direct |
| Sep 28, 2026 | BNTX BioNTech SE | Sale | 34,000 | $98.47 | $3,347,919 | Direct |
1-10 of 26 transactions